Fluoxetine, a selective serotonin reuptake inhibitor, versus desmopressin in primary monosymptomatic nocturnal enuresis: A randomised controlled trial
Fluoxetine 20 mg, a selective serotonin reuptake inhibitor, is non-inferior to desmopressin 0.2 mg for the management of PMNE. Fluoxetine improves nighttime arousal significantly at the first month. This improvement becomes insignificant at the third month.
Authors
- Hesham Torad
- Abdelwahab Hashem (ORCID: https://orcid.org/0000-0002-0664-3504)
- Hesham Abdel-Azim El-Helaly
- A. Soleiman
Institutions
- Jungheinrich (Germany) (DE)
- Cairo University (EG)
- Industrial Union of Metalworkers (DE)
- Mansoura University (EG)
- Mansoura University Hospital (EG)
- Fayoum University (EG)
- Minia University (EG)
Publication Details
- Journal
- Arab Journal of Urology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1080/20905998.2024.2448386
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54